AN ACT relating to administrative regulations for medications for substance use disorder and declaring an emergency.

Create a new section of KRS Chapter 13A to find 201 KAR 9:270 and 201 KAR 20:065 deficient and void; create new sections of KRS Chapters 311, 313, 314, and 315 to establish that the State Board of Medical Licensure, Board of Dentistry, Kentucky Board of Nursing, and Kentucky Board of Pharmacy shall not promulgate administrative regulations that restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the United States Food and Drug Administration for the treatment of a substance use disorder; EMERGENCY.

Introduced: January 7, 2026

Last action: January 14, 2026

To Health Services (H)

Read the full text Kentucky Legislature LegiScan

AI-generated — always verify with primary sources

Plain-language summary

Beta

This bill cancels two existing state administrative regulations related to how certain medications for substance use disorder can be prescribed and dispensed. It also prohibits several state licensing boards, including those overseeing doctors, nurses, dentists, and pharmacists, from creating future rules that limit how those medications are prescribed, dispensed, or administered. The bill takes effect immediately if passed, which is the meaning of the emergency declaration. Who it may affect: Kentuckians being treated for substance use disorder, as well as healthcare providers such as physicians, nurses, dentists, and pharmacists who prescribe or dispense these medications.

Open official bill text (PDF)·Report a problem with the summary